Wie hoch ist der Preis für Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Preis für Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) ist $1.15

Wie hoch ist die Marktkapitalisierung für Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762)

Marktkapitalisierung für Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) ist $88.79M

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762) Dividendenrendite

Based in New Taipei City, Taiwan, Chunghwa Chemical Synthesis & Biotech Co., Ltd., established in 1964 and previously known as China Chemical Synthesis Industry Co., Ltd., specializes in the development, production, and distribution of active pharmaceutical ingredients (APIs). The company's market reach includes Taiwan and the United States. Their API portfolio encompasses products designed for immunosuppression, oncology, and cardiovascular conditions, in addition to various peptide compounds. Moreover, they manufacture a wide array of bulk pharmaceutical substances for numerous therapeutic applications, including anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular medications, skeletal muscle relaxants, hypolipidemics, antineoplastics, antihyperlipidemics, and immunosuppressants. Complementing its product offerings, Chunghwa Chemical Synthesis & Biotech delivers bespoke research and development as well as contract manufacturing services to both emerging drug developers and established generic pharmaceutical firms.

Jahr	Dividendenrendite	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Dividendenrendite

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Dividendenrendite	Land
Royalty Pharma plc RPRX.US	1.58%	US
Swedish Orphan Biovitrum AB SOBI.ST	0.00%	SE
Ipsen S.A. IPN.PA	0.00%	FR
Corcept Therapeutics Incorporated CORT.US	0.00%	US
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	0.00%	IT

Unternehmen

Dividendenrendite

Land